Israel Englander Protalix Bio Therapeutics, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 387,921 shares of PLX stock, worth $903,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
387,921
Previous 373,757
3.79%
Holding current value
$903,855
Previous $381,000
95.28%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PLX
# of Institutions
50Shares Held
4.58MCall Options Held
40.9KPut Options Held
5.3K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.12MShares$2.6 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL732KShares$1.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$776,2880.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$712,3950.04% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$629,1000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $116M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...